Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells.

Autor: Baykal-Köse, Seda¹ (AUTHOR), Acikgoz, Eda^2,3 (AUTHOR), Yavuz, Ahmet Sinan⁴ (AUTHOR), Gönül Geyik, Öykü¹ (AUTHOR), Ateş, Halil⁵ (AUTHOR), Sezerman, Osman Uğur⁶ (AUTHOR), Özsan, Güner Hayri⁵ (AUTHOR), Yüce, Zeynep¹ (AUTHOR) zeynep.sercan@deu.edu.tr

Publikováno v: PLoS ONE. 2/27/2020, Vol. 15 Issue 2, p1-19. 19p.

An Adaptive Phenotypic Shift Leads to TKI Resistance by Acquisition of Leukemic Stem Cell-Like Properties in CML Cells

Autor: GÖNÜL GEYİK, ÖYKÜ, YÜCE, ZEYNEP, SEZERMAN, OSMAN UĞUR, AÇIKGÖZ, EDA, Yavuz, Ahmet Sinan, Baykal Köse, Seda, ÖZSAN, GÜNER HAYRİ, ATEŞ, HALİL

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::0091b345ef1d39a3cc501aaf8409fe71
https://avesis.yyu.edu.tr/publication/details/072adb2a-0e98-41a5-9549-9343402be65a/oai

Investigation of resistance mechanisms against tyrosine kinase inhibitors in chronic myeloid leukemia cell line

Autor: Baykal Köse, Seda

Kronik myeloid lösemi (KML), kimerik Bcr-Abl onkoproteininin sentezlenmesinden sorumlu t(9;22)(q34;q11) translokasyonu ile karakterize bir hematopoetik kök hücre hastalığıdır. KML tedavisinde, imatinib gibi tirozin kinaz inhibitörlerinin Bcr-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_____10208::9fafe6283e2d95b5fd942fde3fa5345a
https://acikbilim.yok.gov.tr/handle/20.500.12812/577889

ENOX2 NADH Oxidase: A BCR-ABL1-Dependent Cell Surface and Secreted Redox Protein in Chronic Myeloid Leukemia

Autor: Baykal-Köse S; İzmir Biomedicine and Genome Center, İzmir, Türkiye; Dokuz Eylül University Faculty of Medicine, Department of Medical Biology, İzmir, Türkiye, Voldoire M; CHD La Roche-sur-Yon-Service de Médecine Onco-Hématologie, La Roche-sur-Yon, Pays de la Loire, France, Desterke C; Université Paris-Saclay BU Kremlin-Bicêtre-Faculté de Médecine, Le Kremlin-Bicetre, Île-de-France, Sorel N; CHU Poitiers-Service de Cancérologie Biologique, Poitiers, France, Cayssials E; CHU Poitiers-Service d’Oncologie Hématologique et Thérapie Cellulaire, Poitiers, France, Johnson-Ansah H; CHRU de Caen-Service d'Hématologie Clinique, Caen, Basse-Normandie, France, Guerci-Bresler A; Hôpital Brabois-Service d'Hématologie Clinique, Vandoeuvre les Nancy, France, Bennaceur-Griscelli A; AP-HP Université Paris Saclay-Service d’Hématologie, Le Kremlin-Bicetre, Île-de-France, France, Chomel JC; INSERM-UA9, Villejuif, Paris, Île-de-France, France, Turhan AG; Paris-Saclay University-Service d'hematologie, Hopital Bicetre, Paris, Villejuif, France

Publikováno v: Turkish journal of haematology : official journal of Turkish Society of Haematology [Turk J Haematol] 2023 May 29; Vol. 40 (2), pp. 101-117. Date of Electronic Publication: 2023 Apr 07.